FDA Approves Antiviral Drug Remdesivir To Treat Hospitalized COVID-19 Patients
On Thursday, drugmaker Gilead Sciences announced that the U.S. Food and Drug Administration approved remdesivir as a treatment for COVID-19. Gilead, which sells remdesivir under the brand name Veklury, issued a statement saying it was the first